GlassScriptPhysician profile
Anthony J Galeo
NPI 1083647630
$3,146.26
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $484 · 2021: $189 · 2023: $711 · 2024: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $716.56 | 2019-2024 | Lifevest |
| Abbott Laboratories | $615.73 | 2019-2024 | Assurity, Jot Dx, Mitraclip |
| Novartis Pharmaceuticals Corporation | $372.33 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $247.87 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.60 | 2019-2024 | Jardiance |
| Boston Scientific Corporation | $163.90 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $108.44 | 2023-2024 | Assure Wcd |
| Baxter Healthcare | $105.24 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $97.44 | 2019-2024 | Repatha |
| Pfizer INC. | $90.75 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $47.16 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $44.00 | 2019 | |
| Edwards Lifesciences Corporation | $43.11 | 2019-2024 | Pascal |
| Medtronic Vascular, INC. | $37.32 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $37.29 | 2023-2024 | Inpefa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35.84 | 2020-2024 | |
| Cardiovascular Systems INC. | $30.83 | 2019 | |
| Cardiva Medical, INC. | $24.68 | 2024 | Optowire |
| Medtronic, INC. | $23.13 | 2023 | Reveal Linq |
| Scpharmaceuticals INC. | $19.03 | 2023 | |
| Ethicon US, LLC | $15.79 | 2024 | Stratafix |
| Biotronik INC. | $14.27 | 2021 | |
| Tactile Systems Technology INC | $13.62 | 2019 | |
| Amarin Pharma, INC. | $12.45 | 2020 | |
| Astellas Pharma US INC | $11.22 | 2019 | |
| Thrombolex, INC. | $10.66 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Galeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.